FUSEN PHARM (01652) Appoints Zhongzheng Tianheng as New Auditor

Stock News
12/24

FUSEN PHARM (01652) announced that KPMG has resigned as the company's auditor effective December 24, 2025, due to the board's failure to reach an agreement on proposed audit fees for the group's consolidated financial statements for the fiscal year ending December 31, 2025. Upon the recommendation of the audit committee, Zhongzheng Tianheng Certified Public Accountants Co., Ltd. has been appointed as the new auditor to fill the vacancy left by KPMG. The appointment takes effect from December 24, 2025, and will remain valid until the conclusion of the company's next annual general meeting.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10